Financials
- Market Capitalization 11.44 B
- Employee 3 221
- Founded N/A
- CEO Alexander Hardy
- Website www.biomarin.com
- Headquarter Delaware, United States
- FIGI BBG000CZWZ05
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
33.02
Fiyat/satışlar oranı
3.64
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 823 | SMMT Summit Therapeutics Inc. - Common Stock | 15.30 USD | +0.33% | -4.20% | +5.96% | -22.96% | 11.88 B USD | ||
| 828 | AXSM Axsome Therapeutics, Inc. - Common Stock | 228.28 USD | -2.36% | -5.79% | -10.25% | +75.33% | 11.75 B USD | ||
| 858 | TECH Bio-Techne Corp - Common Stock | 71.36 USD | +0.08% | +0.62% | +29.02% | +34.67% | 11.17 B USD | ||
| 878 | KRYS Krystal Biotech, Inc. - Common Stock | 363.44 USD | -0.65% | -3.21% | +14.29% | +94.22% | 10.71 B USD |